Old Web
English
Sign In
Acemap
>
authorDetail
>
Marijo Otero-Lobato
Marijo Otero-Lobato
Janssen Pharmaceutica
Golimumab
Medicine
Psoriatic arthritis
Rheumatoid arthritis
Risk management plan
3
Papers
2
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Post-approval Safety Surveillance Study of Golimumab in the Treatment of Rheumatic Disease Using a United States Healthcare Claims Database
2020
Clinical Drug Investigation
Najat Ziyadeh
A. Geldhof
Wim Noël
Marijo Otero-Lobato
Suzan Esslinger
Soumya D. Chakravarty
Yiting Wang
John D. Seeger
Show All
Source
Cite
Save
Citations (0)
SAT0117 TRIMESTER EXPOSURE AND PREGNANCY OUTCOMES IN WOMEN EXPOSED TO GOLIMUMAB – RESULTS FROM THE COMPANY PHARMACOVIGILANCE DATABASE
2020
Annals of the Rheumatic Diseases
Marijo Otero-Lobato
S Esslinger
S Gabriel
M. Clark
P Sheridan
A. Geldhof
Show All
Source
Cite
Save
Citations (0)
Effectiveness of the golimumab educational program in ensuring healthcare professionals’ awareness of risks described in the European risk management plan:
2019
Therapeutic advances in drug safety
Lauren Felo
Marijo Otero-Lobato
A. Geldhof
Wim Noël
Show All
Source
Cite
Save
Citations (2)
1